The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival

Oncogene

Volumn 29, Issue 11, 2010, Pages 1633-1640

  Cheung, M ^a   Pei, J ^a   Pei, Y ^a   Jhanwar, S C ^b   Pass, H I ^c   Testa, J R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genomic imbalances; Mesothelioma; PLZF; Transcription factor; Tumor suppressors

Indexed keywords

CASPASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROMYELOCYTIC LEUKEMIA ZINC FINGER PROTEIN; PROTEIN MCL 1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; ARF GENE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CDKN 2A GENE; CDKN 2B GENE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 9P; CHROMOSOME DELETION; CHROMOSOME LOSS; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOCUS; GENOMICS; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; PLZF GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; REPRESSOR GENE;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL CYCLE; CELL SURVIVAL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MESOTHELIOMA; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 77949652932     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.455     Document Type: Article

References (29)

1. Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, Jhanwar SC, et al. (2005). A mouse model recapitulating molecular features of human mesothelioma. Cancer Res 65: 8090-8095.
2. Balsara BR, Bell DW, Sonoda G, De Rienzo A, du Manoir S, Jhanwar S, et al. (1999). Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. Cancer Res 59: 450-454.
3. Barna M, Merghoub T, Costoya JA, Ruggero D, Branford M, Bergia A, et al. (2002). Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev Cell 3: 499-510.
4. Bernardo MV, Yelo E, Gimeno L, Campillo JA, Parrado A. (2007). Identification of apoptosis-related PLZF target genes. Biochem Biophys Res Commun 359: 317-322.
5. Chen S-J, Zelent A, Tong J-H, Yu H-Q, Wang Z-Y, Derre J, et al. (1993). Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. J Clin Invest 91: 2260-2267.
6. Chen Z, Guidez F, Rousselot P, Agadir A, Chen S-J, Wang Z-Y, et al. (1994). PLZF-RAR-alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci USA 91: 1178-1182.
7. Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee W-C, Altomare DA, et al. (1994). p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54: 5547-5551.
8. Cheng JQ, Lee WC, Klein MA, Cheng GZ, Jhanwar SC, Testa JR. (1999). Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation. Genes Chromosomes Cancer 24: 238-242.
9. Christopher SA, Diegelman P, Porter CW, Kruger WD. (2002). Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res 62: 6639-6644.
10. Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, Sukhwani M, et al. (2004). Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet 36: 653-659.
11. Craighead JE, Mossman BT. (1982). The pathogenesis of asbestos-associated diseases. N Engl J Med 306: 1446-1455.
12. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, et al. (2000). Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20: 1436-1447.
13. Felicetti F, Bottero L, Felli N, Mattia G, Labbaye C, Alvino E, et al. (2004). Role of PLZF in melanoma progression. Oncogene 23: 4567-4576.
14. Frizelle SP, Grim J, Zhou J, Gupta P, Curiel DT, Geradts J, et al. (1998). Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression. Oncogene 16: 3087-3095.
15. Greshock J, Feng B, Nogueira C, Ivanova E, Perna I, Nathanson K, et al. (2007). A comparison of DNA copy number profiling platforms. Cancer Res 67: 10173-10180.
16. Illei PB, Rusch VW, Zakowski MF, Ladanyi M. (2003). Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res 9: 2108-2113.
17. McConnell MJ, Chevallier N, Berkofsky-Fessler W, Giltnane JM, Malani RB, Staudt LM, et al. (2003). Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol Cell Biol 23: 9375-9388.
18. McConnell MJ, Licht JD. (2007). The PLZF gene of t (11;17)-associated APL. Curr Top Microbiol Immunol 313: 31-48.
19. Michels J, O'Neill JW, Dallman CL, Mouzakiti A, Habens F, Brimmell M, et al. (2004). Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene 23: 4818-4827.
20. Murthy SS, Testa JR. (1999). Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelio-ma. J Cell Physiol 180: 150-157.
21. Musti M, Kettunen E, Dragonieri S, Lindholm P, Cavone D, Serio G, et al. (2006). Cytogenetic and molecular genetic changes in malignant mesothelioma. Cancer Genet Cytogenet 170: 9-15.
22. Pei J, Kruger WD, Testa JR. (2006). High-resolution analysis of 9p loss in human cancer cells using single nucleotide polymorphism-based mapping arrays. Cancer Genet Cytogenet 170: 65-68.
23. Rho SB, Chung BM, Lee JH. (2007). TIMP-1 regulates cell proliferation by interacting with the ninth zinc finger domain of PLZF. J Cell Biochem 101: 57-67.
24. Shiraishi K, Yamasaki K, Nanba D, Inoue H, Hanakawa Y, Shirakata Y, et al. (2007). Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression. Oncogene 26: 339-348.
25. Snowden RT, Sun XM, Dyer MJ, Cohen GM. (2003). Bisindolylma-leimide IX is a potent inducer of apoptosis in chronic lymphocytic leukaemic cells and activates cleavage of Mcl-1. Leukemia 17: 1981-1989.
26. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR. (1993). Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53: 4349-4355.
27. Wagner JC, Sleggs CA, Marchand P. (1960). Diffuse pleural mesotheliomas and asbestos exposure in the northwestern cape province. Br J Ind Med 12: 260-271.
28. Yang CT, You L, Yeh CC, Chang JW, Zhang F, McCormick F, et al. (2000). Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells. J Natl Cancer Inst 92: 636-641.
29. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, et al. (1999). Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18: 925-934.